Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2006 > May > 10 > Antiviral Drugs May Fight Shingles Pain
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Healthy Choice News
Site Map Links
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

Antiviral Drugs May Fight Shingles Pain

WEDNESDAY, May 10 (HealthDay News) -- Treatment with oral and intravenous antiviral drugs may ease shingles-related nerve pain, a new study finds.

Shingles, a painful, recurrent nervous disorder, is caused by the varicella-zoster virus.

Researchers at the University of Colorado and Health Sciences Center in Denver gave antiviral treatment to 12 men and three women with moderate to severe pain following shingles. The patients received 10 milligrams of the drug acyclovir intravenously every eight hours for 14 days. They then took three 1,000-milligram pills of the drug valacyclovir per day for one month.

The patients rated their pain on a scale of zero to 10 before they began treatment, then again after completing each therapy, and again one month after completing treatment.

As reported online this week by the journal Archives of Neurology, one month after treatment, eight (53 percent) of the patients reported significant reduction (two or more points) in their pain -- similar to the number of patients who reported similar improvements after day 15 and after day 45.

Five of the patients dropped out of the study early, three of them due to complications caused by the therapy. Most patients tolerated the treatment well, however, the researchers said.

"Although our study was small and without placebo control, the findings suggest a promising effect of antiviral treatment on postherpetic neuralgia [shingles nerve pain]," the study authors concluded. "Treatment of postherpetic neuralgia with IV (intravenous) acyclovir will be expensive. However, elimination or reduction of pain coupled with reduced burden of disease and use of health care resources would offset treatments costs," they added.

The study is expected to appear in the July print issue of the journal Archives of Neurology.

More information

The American Academy of Family Physicians has more about shingles.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, May 8, 2006

Last Updated: May 10, 2006

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement